|03/05/14||Heron Therapeutics Announces Fourth Quarter and Full Year 2013 Financial Results and Highlights Recent Corporate Progress|
|REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Heron Therapeutics, Inc. (HRTX), a specialty pharmaceutical company, today reported fourth quarter and full year 2013 financial results and highlighted recent corporate progress.
“In the last 12 months, we transformed ourselves into Heron Therapeutics and made important advancements to position Heron for success in 2014,” said Barry D. Quart, PharmD, Chief Executive Officer of Heron Therapeutics. “In 2013, we brought in a fresh and highly seasoned mana... |
|01/27/14||Heron Therapeutics Provides Update on Sustol Resubmission|
|REDWOOD CITY, Calif.--(BUSINESS WIRE)--Heron Therapeutics, Inc. (NASDAQ: HRTX), a specialty pharmaceutical company, today announced an approximate one-quarter delay to the Company's timeline for the resubmission of the new drug application (NDA) for Sustol® to the U.S. Food and Drug Administration (FDA), the Company's product candidate for chemotherapy-induced nausea and vomiting (CINV).
"Subject to the FDA's review and approval of the Sustol NDA, we project being in a position to launch Sust... |
|01/23/14||Heron Therapeutics Announces Relisting on NASDAQ |
|January 23, 2014 08:00 AM Eastern Standard Time
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc., OTCBB: APPAD), a specialty pharmaceutical company, today announced that the Company’s common stock has been relisted on the NASDAQ Capital Market. The Company’s shares will trade under the symbol “HRTX” on the NASDAQ Capital Market when the market opens today, Thursday, January 23, 2014.
“We ... |
|01/13/14||A.P. Pharma Announces Appointment of New Directors and Effective Date of Name Change and Reverse Stock Split|
|REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (OTCBB: APPA), a specialty pharmaceutical company, today announced that it has changed its name to Heron Therapeutics, Inc. and effected a 1-for-20 reverse stock split, both effective January 13, 2014. The reverse split is being implemented to increase the Company's stock price in support of the Company's pending application to list on the NASDAQ Capital Market. Assuming satisfaction of listing standards, the Company expects to list on NAS... |